Vasculitis refers to a group of disorders that cause inflammation in your blood vessels. It’s also called angiitis or arteritis. It can cause your blood vessels to become weak, dilated, enlarged, or constricted. Damage to organs and tissues may occur if blood flow is restricted.
Vasculitis has several subtypes, most of which are infrequent. One or more organs may be impacted by vasculitis. Long-term or transient conditions are also possible. Although vasculitis may affect anyone, some forms are more prevalent in particular age groups. The majority of subtypes need medicine to reduce inflammation and minimize flare-ups.
It is unclear what causes vasculitis exactly. Several subtypes are influenced by genetics. Others happen when the immune system unintentionally attacks blood vessel cells. Possible triggers for this immune system reaction include:
The majority of vasculitis types often manifest the following common signs and symptoms:
In accordance with the body parts affected, other signs and symptoms include:
Tests and procedures include –
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
2.
Prostate Cancer Treatment Associated With Long-Term Complications
3.
Unraveling the role of exercise in cancer suppression
4.
Parkinson patient's gait is restored by a spinal cord stimulator.
5.
Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity
1.
The Unseen Danger of Anal Cancer: How to Protect Yourself
2.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
3.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
4.
HCC Codes in Oncology: Care Optimization in Plexiform Neurofibroma Management
5.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part VII
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation